ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2015

Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.

Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.